Perspective Therapeutics (CATX) Return on Sales [ROS] (2010 - 2023)
Perspective Therapeutics (CATX) recorded Return on Sales [ROS] of -2855.02% in Q4 2023, down 2408.80 percentage points from the prior quarter.
Powered by 
Analysis
Perspective Therapeutics (CATX) Return on Sales [ROS] (2010 - 2023) Analysis & Trends
Starting with Q1 2023, Perspective Therapeutics' Return on Sales [ROS] history includes 4 quarters.
- Annual Return on Sales [ROS] has a five-year change of -2741.41 percentage points (FY2018 to FY2023).
- Across earlier years, Return on Sales [ROS] came in at -59.46% in FY2022 (-25.18 pp), -34.28% in FY2021 (+1.63 pp), -35.91% in FY2020 (+35.93 pp) and -71.83% in FY2019 (+41.77 pp).
- Per Business Quant, the preceding three quarters came in at -446.22% (Q3 2023), -467.15% (Q2 2023) and -473.15% (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Perspective Therapeutics | 313.74 Mn | 313.74 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -2,855.02% |
| Sep 30, 2023 | -446.22% |
| Jun 30, 2023 | -467.15% |
| Mar 31, 2023 | -473.15% |
| Sep 30, 2022 | -245.08% |
| Jun 30, 2022 | -84.07% |
| Mar 31, 2022 | -47.29% |
| Dec 31, 2021 | -58.06% |
| Sep 30, 2021 | -88.69% |
| Jun 30, 2021 | -40.33% |
| Mar 31, 2021 | -29.46% |
| Dec 31, 2020 | -37.01% |
| Sep 30, 2020 | -29.95% |
| Jun 30, 2020 | -52.17% |
| Mar 31, 2020 | -19.03% |
| Dec 31, 2019 | -40.93% |
| Sep 30, 2019 | -36.11% |
| Jun 30, 2019 | -59.46% |
| Mar 31, 2019 | -60.45% |
| Dec 31, 2018 | -75.05% |
API Access
Perspective Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CATX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "CATX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CATX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();